Flexible Flat-Rate Plans
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
DrugPatentWatch Database Preview
Bayer Hlthcare Company Profile
« Back to Dashboard
Summary for Applicant: Bayer Hlthcare
| Patents: | 51 |
| Tradenames: | 56 |
| Ingredients: | 38 |
| NDAs: | 57 |
| Drug Master File Entries: (click here to view) | 96 |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | STAXYN | vardenafil hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 200179-001 | Jun 17, 2010 | RX | Yes | 8,613,950 | Dec 23, 2028 | Y | |||||||||||||||||||
Bayer Hlthcare | ANGELIQ | drospirenone; estradiol | TABLET;ORAL | 021355-001 | Feb 29, 2012 | RX | No | 8,906,890 | Oct 22, 2031 | Y | |||||||||||||||||||
Bayer Hlthcare | YAZ | drospirenone; ethinyl estradiol | TABLET;ORAL | 021676-001 | Mar 16, 2006 | RX | Yes | 6,987,101 | Dec 22, 2017 | ||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Similar Applicant Names
Here is a list of applicants with similar names.
« Back to Dashboard
For more information try a trial or see the database preview and plans and pricing
How are People Using DrugPatentWatch?
Patent information on sterle manufactured drugs and when they expire
— Regulatory affairs for a drug compounder, USA
To locate providers of active pharmaceutical ingredients and obtain any patent information that may apply
— Organic chemist at a generic drug manufacturer, USA
To have a global perspective of drug product patents
— Generic drug product company R&D manager, Spain
To know patent expiration dates for different drugs
— Physician, Hungary
To obtain patent expiration information, so that the timeline for registration and launch of our generic products can be optimized.
— Business development manager, generics distribution company, Singapore
To conduct drug patent landscape analysis
— Pharmaceutical R&D, China
To get paragraph IV challenges, detailed regulatory status and tentative approvals
— Dosage form R&D services company, India
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639
